in hypoxia-hypothermia ( p < 0.05 vs. normoxia-normothermia), and 0.5 ± 0.70 in normoxia-hypothermia ( p < 0.05 vs. hypoxia-normothermia). The CaM kinase IV activity in cerebral tissue (pmol Pi/mg protein/min; mean ± SD) was 2,002 ± 729 in normoxia-normothermia, 1,704 ± 18 in normoxiahypothermia, 6,017 ± 2,510 in hypoxia-normothermia, 4,104 ± 542 in hypoxia-hypothermia ( p < 0.05 vs. normoxia-hypothermia), and 2,165 ± 415 in hypoxia-hypothermia with PP2 ( p < 0.05 vs. hypoxia-hypothermia). The hypoxic groups with and without hypothermia or Src kinase inhibitor were comparable in the levels of ATP and PCr, indicating that they were similar in their degree of energy failure prior to treatments. Hypothermia or Src kinase inhibitor (PP2) did not restore the ATP and PCr levels. Conclusions: Hypothermia and Src kinase inhibition attenuated apoptotic cell death and improved neuropathology after hypoxia. The combination of short-duration hypothermia with Src kinase inhibition following hypoxia further attenuates the increased activation of CaM kinase IV compared to hypothermia alone in the newborn swine brain.
Introduction
Current estimates of the incidence of neonatal encephalopathy range from 1 to 8 per 1,000 live births [1] [2] [3] . Approximately 15-20% of affected newborns die in the postnatal period, and an additional 25% may manifest substantial long-term disabilities. Neonates with severe encephalopathy have a high risk of death (85%), cerebral palsy and developmental delay among survivors [1, 4] . Neonates with moderate encephalopathy may have significant motor deficits, memory impairment, visual dysfunction, increased hyperactivity, and learning difficulties [2] .
Decreased oxygen and glucose delivery to the newborn brain during hypoxia-ischemia (HI) leads to primary energy failure, the depletion of high-energy compounds, and activation of a downstream cascade of free radical injury. Excitotoxicity and the induction of a neuroinflammatory response, exacerbated by reperfusion/reoxygenation, lead to secondary energy failure and delayed cell death [5] . Although the initial wave of cell death may occur too rapidly for effective intervention, treatments administered before the onset of secondary energy failure have the potential to attenuate or prevent the later wave of cell death [5, 6] .
Hypothermia has emerged as the standard of care to treat infants with hypoxic-ischemic encephalopathy (HIE) [7] . Several systematic reviews and meta-analysis of term and late preterm infants with moderate/severe encephalopathy and evidence of intrapartum asphyxia concluded that therapeutic hypothermia reduced the combined outcome of mortality or major neurodevelopmental disability. However, the overall rate of death or disability following hypothermia reported in published trials was still 31% to 55% [8] . There remains a need to further optimize cooling strategies and to identify adjuvant therapies that could potentially augment the neuroprotective effects of hypothermia [7] .
Several experimental and pre-clinical studies have documented the effects of hypothermia on the pathogenesis of brain injury in the acute, subacute and chronic stages of hypoxia. Exposure to hypothermia reduces excitotoxicity, free radical production, apoptosis, and inflammation. Hypothermia attenuates the influx of intracellular calcium during HIE, and reduces apoptotic cell death [4] . The mechanism of apoptotic cell death following cerebral hypoxia and the point of action of therapeutic hypothermia and the Src kinase inhibitor is illustrated in Figure 1 .
Our laboratory has focused on molecular mechanisms of hypoxia-induced brain injury, and particularly the enzymes of the apoptotic cascade such as Src kinase and Ca 2+ /calmodulin kinase IV (CaM kinase IV) [9] . We have previously shown that cerebral hypoxia results in increased activity of Src kinase and CaM kinase IV in neuronal nuclei of the cerebral cortex of newborn piglets [10, 11] .
CaM kinase IV, located in the nucleus, phosphorylates the CREB (cyclic-AMP response element-binding) protein, a regulator of the transcription of genes of cell survival or cell death pathways [11, 12] .
We hypothesize that a short duration of hypothermia will attenuate the hypoxia-induced overactivation of CaM kinase IV, and that inhibition of Src kinase in combination with hypothermia will further attenuate the activation of CaM kinase IV compared with hypothermia alone.
Materials and Methods

Experimental Procedures
Studies were performed on 2-to 3-day-old male Yorkshire piglets obtained from the Willow Glenn Farm in Strasburg, PA, USA. The experimental animal protocol was approved by the Institutional Animal Care and Use Committee of Drexel University (IACUC-20401). All methods were performed in accordance with the relevant guidelines and regulations. The appropriate use of drugs was followed during experiments to eliminate pain and suffering, according to the NIH Guidelines for the Use of Laboratory Animals. Five piglets were included in each group for statistical comparison. Anesthesia was induced with 4% isoflurane and maintained with 0.8% isoflurane. The piglets were orally intubated and ventilated within 10 min of the induction of anesthesia. A peripheral IV catheter was inserted for the administration of fluids and medications. Intravenous fentanyl (25 μg/kg) and pancuronium bromide (0.1 mg/kg) were administered following placement on a pressure ventilator using a mixture of 75% nitrous oxide and 25% oxygen. Arterial blood gases and pH were taken every 15 min through a percutaneously placed peripheral arterial line.
Following 1 h of baseline ventilation with normal blood gases, the piglets were randomly assigned to either the normoxic control group, for an additional 60 min of mechanical ventilation in room air, or the hypoxia group. Hypoxia was induced by decreasing the FiO 2 to 0.06 within 5 min, maintained for the 60-min period and titrated to achieve a 40% reduction in systolic BP from baseline. In terms of temperature, the piglets were either maintained at 37-38 ° C (normothermic) or cooled to 33-34 ° C for 4 h, then rewarmed over 6 h (hypothermic-hypothermia). Hypothermia to a target T rectal of 33-34 ° C was achieved by placing the piglet on a neonatal cooling blanket.
The hypoxic piglets that were cooled were subdivided into a group that received Src kinase inhibitor PP2 (HI-hypothermia-PP2) and another group that underwent hypothermia only (HIhypothermia) without the inhibitor. PP2 (4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo [3,4-d] pyrimidine) is a selective and potent inhibitor of Src-kinase (IC 50 = 5 n M ; EMD 39 Bioscience, San Diego, CA, USA). The inhibitor was administered 1 h after HI to mimic the clinical scenario of HIE. After the reoxygenation period, the animals were either transcardially perfused with phosphate-buffered saline and paraformaldehyde for neuropathology studies, or the brain was rapidly harvested and placed in liquid nitrogen and stored at -80 ° C for biochemical studies. For neuropathology studies, the areas of motor and sensory cortex, hippocampus, putamen, and caudate nucleus were prepared and fixed.
Neuropathology
Hypoxic injury was confirmed histologically by hematoxylin and eosin (HE) stain. Upon brain removal, midsagittal sections comprising of cerebrum, brainstem, and cerebellum en block were fixed immediately by immersion in 10% neutral formalin, processed according to standard neurohistological procedures, and embedded in paraffin. Parasagittal sections corresponding to the hippocampus were stained with HE. Sections from the motor cortex, somatosensory cortex, putamen, hippocampus, caudate nucleus, and thalamus were utilized to evaluate the number of viable neurons, apoptotic profiles, pericellular edema, pyknotic nuclei, and vascular thickening. Neuronal cell injury was demonstrated by neuropathology and scored by 2 independent observers. The scores ranged from 0 (normal) to 4 (injured neurons >75% of highpower field) according to the method of Hoque et al. [13] Isolation of Cerebral Cortical Neuronal Nuclei Cerebral cortical nuclei were isolated according to the method of Giufrida et al. [14] and described in our previous studies [11] . Neuronal nuclei were characterized by the presence of 1 nucleolus per nucleus, whereas others have multiple nucleoli per nucleus.
The final nuclear preparation was devoid of any microsomal, mitochondrial, or plasma membrane contaminant with a purity of neuronal nuclei of 90%. Protein content was determined by the method of Lowry et al. [15] .
Determination of Adenosine Triphosphate and Phosphocreatine
Brain tissue concentrations of adenosine triphosphate (ATP) and phosphocreatine (PCr) concentrations were determined according to the method of Lamprecht et al. [16] Cerebral tissue hypoxia was confirmed biochemically by determining the levels of the high-energy phosphates ATP and PCr as described in our previous studies [11] .
Determination of CaM Kinase IV Activity in Neuronal Nuclei
CaM kinase IV activity was determined as described by Park and Soderling [17] and Soderling [18] 2+ /CaM independent activity) and 10 μL neuronal nuclei. The phosphorylated peptide medium (20 μL) was placed on phosphocellulose P81 membranes, washed and dried. The filter was placed in 10 mL of scintillation fluid and the 33P radioactivity was counted. The difference in the presence and absence of CaM was calculated and the enzyme activity was expressed as pmol/mg of protein/min. Fig. 1 . Mechanism of apoptotic cell death following cerebral hypoxia. Note the point of action (marked with X ) of hypothermia and the Src kinase inhibitor (PP2). Following the inhibition of Src kinase, the activation of other enzymes, such as CaM kinase IV and caspase 9 and 3 have been shown to be decreased.
Statistical Analysis
The statistical analysis of the data on ATP, PCr, and CaM kinase IV activity was performed using 1-way analysis of variance. A p value <0.05 was considered significant. Pairwise comparison between the groups was done by Tukey test.
Results
High-Energy Phosphates
Cerebral hypoxia was confirmed by determining the levels of ATP and PCr (μmoles/g brain tissue) to assess whether the hypoxic groups with and without the inhibitor were comparably hypoxic. The ATP and PCr levels in the different groups are shown in Table 1 . The hypoxic groups with and without hypothermia or Src kinase inhibitor were comparable in the levels of ATP and PCr, indicating that they were similar in their degree of energy failure prior to treatments. Administration of hypothermia or Src kinase inhibitor (PP2) did not restore the ATP and PCr levels.
Neuropathology
The neuropathology mean score (mean ± SD) was 0.4 ± 0.43 in normoxia-normothermia ( p < 0.05 vs. hypoxianormothermia), 3.5 ± 0.89 in hypoxia-normothermia ( p < 0.05 vs. normoxia-normothermia), 0.7 ± 0.73 in hypoxia-hypothermia ( p < 0.05 vs. hypoxia-normothermia), and 0.5 ± 0.70 in normoxia-hypothermia ( p < 0.05 vs. hypoxia-normothermia). Morphologically, the neurons were damaged, with pyknotic nuclei, ruptured or irregularly bordered nuclear membranes, and a marked presence of apoptotic profiles ( Fig. 2 ) . However, hypothermia resulted in fewer damaged neurons, less karyorrhexis and pericellular edema, and thus attenuated neuronal cell injury compared to the group exposed to hypoxia without hypothermia or Src kinase inhibition.
CaM Kinase IV Activity
CaM kinase IV activity in cerebral tissue (pmol Pi/mg protein/min; mean ± SD) was 2,002 ± 729 in normoxianormothermia, 1,704 ± 18 in normoxia-hypothermia, 6,017 ± 2,510 in hypoxia-normothermia, 4,104 ± 542 in hypoxia-hypothermia ( p < 0.05 vs. normoxia-hypothermia), and 2,165 ± 415 in hypoxia-hypothermia with PP2 ( p < 0.05 vs. hypoxia-hypothermia). CaM kinase IV activation increased following hypoxia. However, treatment with short-duration hypothermia attenuated the CaM kinase IV activation and Src kinase inhibition, when used concurrently with hypothermia, further reduced the activation of CaM kinase IV similar to the normoxia levels ( Fig. 3 ) . The hypoxic groups with and without hypothermia (HT) or Src kinase inhibitor were comparable in levels of adenosine triphosphate (ATP) and phosphocreatine (PCr), indicating that they were similar in their degree of energy failure prior to treatments. Administration of HT or Src kinase inhibitor (PP2) did not restore the ATP and PCr levels. 
Discussion
The present study showed that using small-molecule inhibitors in combination with hypothermia acts synergistically and further attenuates the overactivation of apoptotic enzymes when compared to hypothermia alone. Studies have shown that hypothermia may attenuate the neuronal injury caused by HI and reperfusion by decreasing the metabolism, limiting the cell and mitochondrial membrane leakage, reducing the calcium influx into the cell, decreasing excitotoxicity and the production of free radicals, and by decreasing the activation of apoptotic enzymes such as caspase 3 and 9, Src kinase, and CaM kinase IV [19] [20] [21] [22] . However, following the inhibition of Src, the activation of other enzymes, such as CaM kinase IV and caspase 3 and 9, has been shown to be decreased. Growing evidence indicates that nonreceptor tyrosine kinases have been implicated in the hypoxia-induced neonatal brain injury in preclinical studies [22] . Single-protein inhibition with small molecules resulted in satisfactory in vivo results in the HI porcine model [10, 22] . In order to ensure adequate energy failure after hypoxia, we measured the high-energy compounds in the groups and our hypoxic groups were very comparable in ATP and PCr levels. Hypothermia or Src inhibition did not restore the energy failure, but they were applied 1 h following the hypoxia.
A significant advantage of the combination treatment of hypothermia with the inhibitors is their existing clinical establishment in other medical fields, such oncology or rheumatology [23] . The newborn porcine shares comparative developmental ontogeny with the term newborn human brain, and the pattern of hypoxic brain injury in piglets is similar to that in hypoxic human infants [24] . We and other investigators have used the porcine animal model, in contrast to a rodent model of HIE, as it provides the advantage of being able to make real-time measurements of physiologic parameters, such as arterial blood gases and continuous blood pressure monitoring, which allows titration of the FiO 2 to achieve a precise and reproducible degree of HI [24] .
CaM kinase IV is a multifunctional CaM-dependent kinase protein with limited tissue distribution that has been implicated in transcriptional regulation in neurons [11, 25] . In our previous studies we showed that Src kinase inhibition without hypothermia attenuated the activity of CaM kinase IV, but only to a certain level (3,700 ± 532 in HI-PP2 ( p < 0.05 vs. HI, p = not significant vs. normoxia) [11] . We showed here that hypothermia has an additive role and further decreased the CaM kinase IV activity when combined with small molecules.
CaM kinase IV phosphorylates and activates CREB, a key transcription factor. We have previously shown increased activation of apoptotic pathway mediators, such as cytosolic nonreceptor protein tyrosine kinase, Src kinase, and nuclear CaM kinase IV in the porcine brain acutely after HI [11, 18] . Inhibition of Src kinase prevented HI-induced activation of CaM Kinase IV and reduced HI cerebral injury in normothermic piglets [5] .
Inhibition of Src kinase prevented the hypoxia-induced increase in tyrosine phosphorylation of calmodu- lin at Tyr99 and CaM kinase IV. This shows that it is the Src kinase that mediates the increased Tyr phosphorylation of calmodulin and CaM kinase IV in the neuronal nuclei of the cerebral cortex of newborn piglets [12] .
Our data suggest that blockade of the apoptotic pathway works synergistically with hypothermia and further attenuates the overactivation of the apoptotic enzymes. Since HI cannot be predicted beforehand, agents such as PP2 that target mechanisms mediating the early stages of injury may provide a novel adjunct therapy to hypothermia in the post-HI period to further improve outcomes of HIE.
The present study demonstrated that hypoxia resulted in the increased activation of CaM kinase IV, which was attenuated by a short duration therapeutic hypothermia and was further reduced by combined hypothermia and Src inhibition in the newborn porcine HI model. We showed that the hypoxia-induced increased activation of apoptotic proteins is attenuated by the inhibition of Src kinase, which acted synergistically with hypothermia. Together with our previous studies, these data further elucidate the effects of Src kinase on the apoptotic cascade, and identify Src kinase as a potential target to interrupt cell death pathways.
In the course of perinatal HI-reperfusion insult, oxidative stress may be reduced by the concurrent administration of a selective inhibitor of Src kinase (PP2) with hypothermia, even if this reduction serves as one of the mechanisms of action in therapeutic hypothermia.
Limitations
It was not deemed feasible to perform all studies (biochemical assays and histopathology) on the same animals. Biochemical studies such as high-energy compounds and enzyme assays require the deep freezing of brain tissue to -80 ° C within 5-10 s of harvesting. Conversely, transcardial perfusion and tissue fixation is required for neuropathology. Although an ultrashort duration of hypothermia was performed, changes in enzymatic activity occur very rapidly.
Data Availability
The datasets generated during and/or analyzed during the current study are available from Dr. Maria Delivoria-Papadopoulos' Laboratory at Drexel University College of Medicine, Philadelphia, PA, USA.
